NeuPath Health Income Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	83.93	72.81	66.1	62.65	60.86	47.64
Revenue	83.93	72.81	66.1	62.65	60.86	47.64
Revenue Growth (YoY)	18.67%	10.14%	5.50%	2.95%	27.74%	-4.03%
Cost of Revenue	67.78	58.95	53.81	51.83	49.8	37.92
Gross Profit	16.16	13.86	12.3	10.82	11.06	9.72
Selling, General & Admin	11.52	10.15	9.25	9.41	9.95	8.04
Operating Expenses	13.84	12.45	11.86	12.08	12.97	10.54
Operating Income	2.32	1.41	0.44	-1.26	-1.91	-0.82
Interest Expense	-0.92	-0.95	-0.93	-0.83	-0.88	-1.47
Interest & Investment Income	-	-	0.01	0.02	0.03	0.05
Other Non Operating Income (Expenses)	-	-	-	-	-	-0.56
EBT Excluding Unusual Items	1.4	0.46	-0.48	-2.07	-2.76	-2.81
Merger & Restructuring Charges	-1.21	-0.72	-0.23	-0.58	-0.56	-
Gain (Loss) on Sale of Assets	-0.02	-0.02	0.76	-	-	-
Asset Writedown	-	-	-	-1.94	-	-
Other Unusual Items	-	-	-	0.5	0.07	-2.05
Pretax Income	0.18	-0.27	0.06	-4.08	-3.25	-4.86
Income Tax Expense	0.44	0.21	0.25	0.19	-0.02	0.2
Earnings From Continuing Operations	-0.26	-0.49	-0.19	-4.28	-3.23	-5.06
Minority Interest in Earnings	-0.29	-0.24	0.08	0.13	-	-
Net Income	-0.55	-0.73	-0.11	-4.14	-3.23	-5.06
Net Income to Common	-0.55	-0.73	-0.11	-4.14	-3.23	-5.06
Shares Outstanding (Basic)	56	56	55	48	45	24
Shares Outstanding (Diluted)	56	57	55	48	45	24
Shares Change (YoY)	0.15%	3.54%	14.44%	7.40%	84.24%	56.61%
EPS (Basic)	-0.01	-0.01	-0.00	-0.09	-0.07	-0.21
EPS (Diluted)	-0.01	-0.01	-0.00	-0.09	-0.07	-0.21
Free Cash Flow	2.87	1.66	2.68	-0.49	1.51	-0.68
Free Cash Flow Per Share	0.05	0.03	0.05	-0.01	0.03	-0.03
Gross Margin	19.25%	19.03%	18.60%	17.27%	18.17%	20.40%
Operating Margin	2.76%	1.93%	0.67%	-2.00%	-3.14%	-1.72%
Profit Margin	-0.66%	-1.00%	-0.16%	-6.61%	-5.31%	-10.62%
Free Cash Flow Margin	3.42%	2.28%	4.05%	-0.79%	2.48%	-1.44%
EBITDA	3.35	2.43	1.62	-0.17	-0.26	0.6
EBITDA Margin	4.00%	3.33%	2.45%	-0.27%	-0.43%	1.25%
D&A For EBITDA	1.04	1.02	1.18	1.08	1.65	1.42
EBIT	2.32	1.41	0.44	-1.26	-1.91	-0.82
EBIT Margin	2.76%	1.93%	0.67%	-2.00%	-3.14%	-1.72%
Effective Tax Rate	245.51%	-	447.27%	-	-	-
Revenue as Reported	83.93	72.81	66.1	62.65	60.86	47.64

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.